🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT07465263Heterozygous Familial Hypercholesterolemia (HeFH)
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
135
Beijing
2026-03-31
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
NCT07515014Systemic Lupus Erythematosus
Eisai Co., Ltd.
Phase 2
256
Bengbu, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Guiyang, Luoyang
2026-03-31
Not yet open
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)
NCT07507825Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou
Phase 2
61
Hangzhou
2026-03-31
Recruiting
Immediate Electrophysiological Effects of Different Atrial Pacing Sites on P-Wave Characteristics
NCT07603648Pacing Therapy, Cardiac Pacing
Shanghai Tong Ren Hospital
Not applicable
35
Zunyi, Shanghai
2026-03-31
Recruiting
BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
NCT07469774Locally Advanced or Metastatic Solid Tumors
Biocity Biopharmaceutics Co., Ltd.
Phase 1/2
111
Guangzhou
2026-03-31
Recruiting
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
NCT07466238Biliary Tract Cancer (BTC)
Peking University
Not applicable
40
Beijing
2026-03-31
Not yet open
A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy
NCT07421284Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
900
Beijing
2026-03-31
Recruiting
A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
NCT07488065Atopic Dermatitis
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Shanghai
2026-03-31
Active, closed
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
NCT07651475R/R AML
Liping Dou
Phase 2
32
Beijing
2026-03-31
Not yet open
Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion
NCT07460713Ischemic Stroke, Large Vessel Occlusion
Beijing Tiantan Hospital
Not applicable
568
Beijing
2026-03-31
Active, closed
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
NCT07749703Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
346
Hefei, Shenyang, Jinan, Shanghai, Hangzhou
2026-03-31
Not yet open
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
NCT07469956Pancreatic Cancer Resectable
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-03-31
Not yet open
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping
NCT07511114DLBCL - Diffuse Large B Cell Lymphoma, Double Expressor Lymphoma
Ruijin Hospital
Phase 3
156
Shanghai
2026-03-31
Not yet open
A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
NCT07393451Lupus Nephritis
Simcere Pharmaceutical Co., Ltd
Phase 2
60
Beijing
2026-03-31
Recruiting
Cosiporfin Sodium for Injection Photodynamic Therapy
NCT07398339Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd
Phase 2
30
Shanghai
2026-03-31
Recruiting
The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL
NCT07514169Large B-Cell Lymphoma (LBCL)
Ruijin Hospital
Phase 2
30
Shanghai
2026-03-31
Recruiting
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
NCT07516522Ischemia Stroke, Thrombectomy, Large Vessel Occlusion
Tang-Du Hospital
Phase 2
210
Xi'an
2026-03-31
By invitation
Study on the Correlation Between Plasma Orexin Levels During the Recovery Period and Emergence Delirium in Elderly Patients
NCT07726875Emergence Delirium, Anesthesia
Ruijin Hospital
Observational
150
Shanghai
2026-03-31
Recruiting
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
NCT07329322Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
30
Beijing
2026-03-30
Not yet open
Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions
NCT07507071Early Gastric Cancer
Changhai Hospital
Observational
169
Shanghai
2026-03-30
Recruiting
A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function
NCT07694843Healthy Participants, Participants With Mild Hepatic Impairment, Participants With Moderate Hepatic Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
24
Suzhou
2026-03-30
Not yet open
Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery
NCT07385209Congenital Heart Disease
ruijie YangLan
Not applicable
210
Kunming
2026-03-30
Recruiting
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
NCT07339774Radiotherapy-induced Oral Mucositis
West China Hospital
Phase 2
128
Chengdu
2026-03-30
Recruiting
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
NCT07418749Recurrent Cervical Cancer, Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
398
Guangzhou
2026-03-30
Recruiting
Air Purifier Use and Respiratory Health in COPD Patients
NCT07505602Respiratory Health
Fudan University
Not applicable
120
Shanghai
2026-03-30
Recruiting
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
NCT07455734Advanced Solid Tumor Cancer
BioNTech SE
Phase 1/2
533
Chongqing, Guangzhou, Hangzhou, Shanghai, Tianjin
2026-03-30
Recruiting
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
NCT06889610Triple Negative Breast Cancer Metastatic, Melanoma Metastatic, Colorectal Cancer Metastatic
Fudan University
Phase 2
95
Shanghai
2026-03-30
Recruiting
A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT07269717Heart Failure With Preserved Ejection Fraction
Shandong Suncadia Medicine Co., Ltd.
Phase 2
48
Shanghai
2026-03-30
Active, closed
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
NCT07499050Healthy Volunteers, Overweight or Obesity
Hoffmann-La Roche
Phase 1
30
Nanjing, Shanghai
2026-03-30
By invitation
Knee Pain Ejiao Paste for Knee Osteoarthritis
NCT07504562Knee Osteoarthritis
ShuGuang Hospital
Phase 2
60
Shanghai
2026-03-30
Recruiting
Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
NCT07519109Postoperative Pain
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
60
Changsha
2026-03-30
Not yet open
Real-World Study on Efficacy and Influencing Factors of Immunotherapy for Pan-Cancer Lymph Node Metastases.
NCT07540377Malignant Solid Tumors With Lymph Node Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
5,000
Guangzhou
2026-03-30
Recruiting
Transcranial Direct Current Stimulation for Depression
NCT07500064Depression
The Second Hospital of Anhui Medical University
Not applicable
50
Hefei
2026-03-30
Not yet open
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
NCT07487402Hepatocellular Carcinoma (HCC)
Zhejiang University
Phase EARLY_PHASE1
27
Hangzhou
2026-03-30
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
NCT07535762Peripheral T-Cell Lymphoma (PTCL NOS), Nodal T-follicular Helper Cell Lymphoma, Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
Shanghai Jiao Tong University School of Medicine
Phase 2
36
Shanghai, Wuxi
2026-03-30
Recruiting
Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?
NCT07322705Femoroacetabular Impingement Syndrome
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Tai’an, Shanghai, Chengdu
2026-03-30
Recruiting
Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma
NCT07560488HCC - Hepatocellular Carcinoma, Conversion Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2
43
Tianjin
2026-03-30
Not yet open
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
NCT06943794Gastric (Stomach) Cancer
Fudan University
Not applicable
4,824
Tongling
2026-03-30
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
NCT07535710Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, Sezary Syndrome, Cutaneous T Cell Lymphoma (CTCL)
Shanghai Jiao Tong University School of Medicine
Phase 1/2
37
Shanghai, Wuxi
2026-03-30
Recruiting
Effect of Postoperative Analgesia of Oliceridine Fumarate for Gastrointestinal Function Recovery in Patients Undergoing Lumbar Spine Surgery
NCT07307495Oliceridine Fumarate
Xijing Hospital
Not applicable
428
Xi'an
2026-03-30
Recruiting
Dihydroartemisinin for MAFLD
NCT07679542MAFLD
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
30
Nanjing
2026-03-30
Not yet open
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC
NCT07549061Lung Neoplasms
Shanghai Chest Hospital
Phase 2
19
Shanghai
2026-03-30
Recruiting
The Effect of Braun Anastomosis on Delayed Gastric Emptying (DGE) in Reconstruction After Pancreaticoduodenectomy
NCT07681128Periampullary Carcinoma Resectable
Tianjin Medical University Cancer Institute and Hospital
Not applicable
264
Tianjin
2026-03-30
Recruiting
Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery
NCT07383909Aortic Dissection Type A
Fujian Medical University
Not applicable
1,312
Hefei, Fuzhou, Xiamen, Guangzhou, Harbin, Zhengzhou, Changsha, Dalian
2026-03-29
Recruiting
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
NCT07180277Traumatic Brain Injury
Zhangjiagang First People's Hospital
Phase 4
520
Suzhou
2026-03-29
Recruiting
The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
NCT07507513Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
288
Guangzhou
2026-03-28
Not yet open
Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy
NCT07263867Colonoscopy, Bowel Preparation, Quality of Healthcare
LanZhou University
Not applicable
300
Lanzhou
2026-03-28
By invitation
Clinical Study on the Treatment of Gastrointestinal Dysfunction After Knee Joint Surgery Under General Anesthesia With Floating Needle
NCT07607249Gastrointestinal Dysfunction
Zhenyu Zhang
Not applicable
72
Guangzhou
2026-03-27
Recruiting
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
NCT07084519Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
506
Beijing
2026-03-27
Recruiting
Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
NCT07483372Resistant Arterial Hypertension, Chronic Kidney Disease (Stage 3-4)
The First Affiliated Hospital with Nanjing Medical University
Phase 1
3
Suzhou
2026-03-27
Recruiting
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
NCT07300514Maintenance Treatment of Peripheral T-cell Lymphoma
Fudan University
Phase 3
136
Shanghai
2026-03-27
Not yet open
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
NCT07417306Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
912
Beijing
2026-03-27
By invitation
Pantoprazole After Prophylactic Endoscopic Variceal Treatment
NCT07248722Esophageal and Gastric Varices, Liver Cirrhosis
General Hospital of Shenyang Military Region
Not applicable
208
Shenyang
2026-03-27
Not yet open
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
NCT07491783HNSCC, Soft Tissue Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 2
52
Chengdu
2026-03-27
Not yet open
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy
NCT07501832Obstructive Sleep Apnea (OSA)
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-03-27
Recruiting
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
NCT07493044Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
15
Guangzhou
2026-03-27
Recruiting
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma
NCT07518602Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University
Phase 2
34
Guangzhou
2026-03-27
Recruiting
A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.
NCT07490262Hepatocellular Carcinoma (HCC)
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 2/3
680
Hefei, Shanghai
2026-03-27
Not yet open
Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy
NCT07489157Hypoxemia
Chinese PLA General Hospital
Not applicable
460
Beijing
2026-03-27
Not yet open
A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy
NCT07414927Small Cell Carcinoma of Lung
Shanghai Best-Link Bioscience, LLC
Phase 1/2
48
Shanghai
2026-03-27
Recruiting
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
NCT07389733Advanced Unresectable or Metastatic Breast Cancer of Adults
Shandong Suncadia Medicine Co., Ltd.
Phase 1/2
180
Dalian, Chengdu
2026-03-27
Recruiting
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
NCT07405151Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 1/2
60
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Jinan, Hangzhou
2026-03-27
Not yet open
A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.
NCT07449156Acne Vulgaris
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1/2
21
Jinan
2026-03-27
Recruiting
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
NCT07478822Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.
Phase 3
300
Beijing, Chengdu, Guangdong, Guangzhou, Hefei, Huai'an, Kaifeng, Kunming
2026-03-27
Recruiting
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
NCT06968936Anemia, Iron Deficiencies, Cardiac Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hangzhou
2026-03-27
Recruiting
Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
NCT07625423Head & Neck Cancer, Nasopharyngeal Cancinoma (NPC)
West China Hospital
Phase 1
9
Chengdu
2026-03-27
Recruiting
A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis
NCT07453004Acute Gouty Arthritis
TJ Biopharma Co., Ltd.
Phase 2
170
Shanghai
2026-03-26
Recruiting
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
NCT07415551Allergic Diseases, Chronic Spontaneous Urticaria (CSU)
Yuhan Corporation
Phase 2
150
Guangzhou, Shenzhen
2026-03-26
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Binzhou, Changzhou, Chengdu, Chongqing, Foshan, Guangzhou, Harbin, Hefei
2026-03-26
Recruiting
A Study of BGM0504 Tablets in Healthy Chinese Subjects
NCT07566572Chinese Healthy Volunteers
BrightGene Bio-Medical Technology Co., Ltd.
Phase 1
144
Hangzhou
2026-03-26
Recruiting
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
NCT07447986Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
120
Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Shenzhen, Guilin, Nanning
2026-03-26
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
NCT07493265Narcolepsy
Eisai Inc.
Phase 2
64
Beijing, Changchun, Guangdong, Guangzhou, Jinan, Nanchang, Shanghai, Zhengzhou
2026-03-26
Recruiting
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
NCT07388680Radiation-induced Lung Injury, Immune-related Pneumonia
Beijing Continent Pharmaceutical Co, Ltd.
Phase 2/3
298
Hefei, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Maoming, Shenzhen
2026-03-26
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals
Phase 2
32
Beijing, Shanghai
2026-03-26
Not yet open
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
NCT07474064Muscle Invasive Bladder Cancer (MIBC)
chenxu
Phase 2
146
Guangzhou
2026-03-26
Active, closed
Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection
NCT07826585Advanced Solid Tumors
Corregene Biotechnology Co., Ltd
Phase 1
6
Beijing
2026-03-26
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb
Phase 1/2
474
Beijing, Guangzhou, Tianjin, Harbin, Changsha Shi, Nanjing, Shanghai Shi
2026-03-26
Recruiting
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
NCT07479446PONV, Cerebellopontine Angle Tumor, Microvascular Decompression Surgery, Postoperative Analgesia
Xuanwu Hospital, Beijing
Not applicable
174
Beijing
2026-03-25
Active, closed
Development of a Precision Nutrition Expert System Combining AI Dietary Image Recognition and Big Data Analysis: A Case Study on Kidney Disease
NCT07829991Chronic Kidney Disease
China Medical University Hospital
Not applicable
50
2026-03-25
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)
NCT07375953Ischemic Stroke
General Hospital of Shenyang Military Region
Phase 2
120
Shenyang
2026-03-25
Not yet open
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
NCT07530224Immune Checkpoint Inhibitor-Induced Dermatitis
Shixiu Wu
Phase 2
35
Quzhou
2026-03-25
Not yet open
Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
NCT07469293Acute Ischemic Stroke
Southwest Hospital, China
Phase 3
488
Baise City, Guilin, Qiannan, Chengdu, Dali, Qujing, Ankang, Anyang
2026-03-25
Recruiting
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
NCT07354061NSCLC (Non-small Cell Lung Cancer)
Tang-Du Hospital
Phase 1/2
20
Xi’an
2026-03-25
Recruiting
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
NCT07450976Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
151
Beijing, Shanghai
2026-03-25
Not yet open
A Study of BEN301 Injection in the Treatment of Autoimmune Diseases
NCT07502859SSC RA SS IIM
Beijing Boren Hospital
Phase EARLY_PHASE1
24
Beijing, Shanghai
2026-03-25
Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810Epidemic Meningitis, Meningococcal Vaccines
Sinovac Biotech Co., Ltd
Phase 3
880
Nanning, Taiyuan
2026-03-25
Recruiting
A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC
NCT07422753Hepatocellular Carcinoma (HCC)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
36
Hangzhou
2026-03-25
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NCT07462091Cirrhosis, Hypersplenism, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
15
Yangzhou
2026-03-25
Recruiting
Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
NCT07822152Diabetic Nephropathy
Tongji Hospital
Phase 1
15
Wuhan
2026-03-25
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
NCT07375966Ischemic Stroke
General Hospital of Shenyang Military Region
Phase 2
198
Shenyang
2026-03-25
Not yet open
A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.
NCT07407634Non-Alcoholic Fatty Liver Disease
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Phase EARLY_PHASE1
94
Jilin City
2026-03-25
Recruiting
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
NCT07541664Neoadjuvant Therapy
Fudan University
Not applicable
66
Shanghai
2026-03-25
Recruiting
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
NCT07255898Multiple Myeloma, Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
33
Chengdu
2026-03-25
Not yet open
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
NCT07483749Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia
The Children's Hospital of Zhejiang University School of Medicine
Observational
400
Hangzhou, Ningbo
2026-03-25
Not yet open
Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer
NCT07466303Breast Cancer, Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
Xijing Hospital
Phase 2
84
Xi'an
2026-03-25
Recruiting
ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
NCT07759934Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 2
60
Nanjing
2026-03-25
Recruiting
A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants
NCT07442591Healhty
Shanghai WD Pharmaceutical Co., Ltd.
Phase 1
12
Shanghai
2026-03-24
Recruiting
A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy
NCT07487896Advanced Esophageal Squamous Cell Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
440
Anqing, Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou
2026-03-24
Recruiting
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)
NCT07462546Artery Stenosis
General Hospital of Shenyang Military Region
Not applicable
232
Shenyang
2026-03-24
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709Huntington Disease
Novartis Pharmaceuticals
Phase 3
770
Guangzhou, Wuhan, Changsha, Chengdu, Hangzhou
2026-03-24
Rows per page Showing 3101–3200 of 19052
Previous 30 31 32 33 34 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=32

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.